Generic Version of Copaxone Available
- Pollack A. Teva Ruling Clears Way for Generic Version of Multiple Sclerosis Drug. The New York Times. June 2015.
- Barkber J. US appeals court invalidates patent for Teva's Copaxone, allowing launch of Novartis, Momenta's generic. FirstWord Pharma. June 2015.
- Barber J. Novartis, Momenta receive FDA approval for first generic version of Teva's Copaxone. FirstWord Pharma. April 2015.
- Pollack A. Generic Version of Copaxone, Multiple Sclerosis Drug, Is Approved. The New York Times. April 2015.